Short‐acting inhaled muscarinic antagonists vs placeboAdverse events  · adults and children with cystic fibrosis1 finding from 1 reviewShort‐acting inhaled bronchodilators for cystic fibrosis 2022 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 27 participantsVery low
Short‐acting inhaled beta‐2 agonists vs short‐acting inhaled muscarinic antagonistsAdverse events  · adults and children with cystic fibrosis1 finding from 1 reviewShort‐acting inhaled bronchodilators for cystic fibrosis 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 17 participantsVery low